REGN logo

REGN EV/EBITDA

Current (TTM)14.34×
REGN Quarterly EV/EBITDA (0.00× → 38.50×)
High-resolution chart · PNG

REGN ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals EV/EBITDA — Quarterly
Period endingEV/EBITDA
-82.2706×
-48.5347×
-156.4962×
-79.0074×
-357.1775×
-123.3916×
1,847.4612×
-54.4717×
-30.2363×
-19.1312×
-37.2265×
-147.6765×
172.6×
-54.8×
107.4073×
-3,208.5×
-91.2575×
-63.8336×
-133.7826×
-166.6818×
-173.9106×
-87.7946×
-186.3878×
-380.4088×
871×
-230.6364×
-11.7546×
-33.8278×
-8.4889×
-14.0054×
-24.4225×
-26.4178×
-27.9299×
-27.0706×
-31.556×
-22.8896×
-52.3792×
-78.4082×
-73.1029×
-81.3261×
-71.1944×
0×
-43.263×
0×
0×
0×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.